By Kaila White | The Republic
Within a month or two, Arizona researchers will accept applications for a small number of veterans who have post-traumatic stress disorder to participate in a study in north Phoenix on medical marijuana’s effects on the disorder.
The study is federally approved by the Food and Drug Administration and licensed by the Drug Enforcement Administration. It will study 38 veterans in Phoenix and another 38 at Johns Hopkins University in Baltimore.
It is the first time the DEA and FDA have approved randomized, controlled research intended to develop the actual plant, not oils or synthetics, into a prescription drug to treat PTSD.
